Aurora Cannabis to Host First Quarter 2026 Investor Conference Call
Aurora Cannabis (NASDAQ: ACB), a leading global medical cannabis company, has announced its upcoming first quarter 2026 earnings conference call. The event will take place on Wednesday, August 6, 2025, at 8:00 a.m. Eastern Time.
The company will release its Q1 2026 financial results before markets open on the same day. The conference call will be hosted by Miguel Martin, Executive Chairman and CEO, and Simona King, CFO, and will include a question and answer session. Investors can access the webcast through Aurora's investor relations website.
Aurora Cannabis (NASDAQ: ACB), una delle principali aziende globali nel settore della cannabis medica, ha annunciato la sua prossima conference call per la presentazione dei risultati del primo trimestre 2026. L'evento si terrà mercoledì 6 agosto 2025 alle 8:00 del mattino, ora orientale.
La società pubblicherà i risultati finanziari del primo trimestre 2026 prima dell'apertura dei mercati lo stesso giorno. La conference call sarà condotta da Miguel Martin, Presidente Esecutivo e CEO, e da Simona King, CFO, e includerà una sessione di domande e risposte. Gli investitori potranno seguire la diretta web tramite il sito delle relazioni con gli investitori di Aurora.
Aurora Cannabis (NASDAQ: ACB), una empresa líder mundial en cannabis medicinal, ha anunciado su próxima llamada de conferencia para los resultados del primer trimestre de 2026. El evento se llevará a cabo el miércoles 6 de agosto de 2025 a las 8:00 a.m., hora del este.
La compañía publicará sus resultados financieros del primer trimestre de 2026 antes de la apertura de los mercados ese mismo día. La llamada será dirigida por Miguel Martin, Presidente Ejecutivo y CEO, y Simona King, CFO, e incluirá una sesión de preguntas y respuestas. Los inversores podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversores de Aurora.
Aurora Cannabis (NASDAQ: ACB), 글로벌 선도 의료� 대마초 기업� Aurora Cannabis가 2026� 1분기 실적 컨퍼런스 � 일정� 발표했습니다. 행사� 2025� 8� 6� 수요� 동부 시간 오전 8�� 진행됩니�.
회사� 같은 � 시장 개장 전에 2026� 1분기 재무 결과� 발표� 예정입니�. 컨퍼런스 콜은 미구� 마틴 회장 � CEO와 시모� � CFO가 주최하며 질의응답 시간� 포함됩니�. 투자자들은 Aurora� 투자� 관� 웹사이트� 통해 웹캐스트� 접속� � 있습니다.
Aurora Cannabis (NASDAQ : ACB), une entreprise mondiale de premier plan dans le domaine du cannabis médical, a annoncé sa prochaine conférence téléphonique pour les résultats du premier trimestre 2026. L'événement aura lieu le mercredi 6 août 2025 à 8h00, heure de l'Est.
La société publiera ses résultats financiers du premier trimestre 2026 avant l'ouverture des marchés le même jour. La conférence téléphonique sera animée par Miguel Martin, président exécutif et PDG, ainsi que par Simona King, directrice financière, et comprendra une session de questions-réponses. Les investisseurs pourront accéder au webcast via le site des relations investisseurs d'Aurora.
Aurora Cannabis (NASDAQ: ACB), ein weltweit führendes Unternehmen im Bereich medizinisches Cannabis, hat seine bevorstehende Telefonkonferenz zur Bekanntgabe der Ergebnisse des ersten Quartals 2026 angekündigt. Die Veranstaltung findet am Mittwoch, den 6. August 2025, um 8:00 Uhr Eastern Time statt.
Das Unternehmen wird die Finanzergebnisse für das erste Quartal 2026 am selben Tag vor Markteröffnung veröffentlichen. Die Telefonkonferenz wird von Miguel Martin, Executive Chairman und CEO, sowie Simona King, CFO, geleitet und beinhaltet eine Fragerunde. Investoren können den Webcast über die Investor-Relations-Website von Aurora verfolgen.
- None.
- None.
NASDAQ | TSX: ACB
Conference Call Details
DATE: | Wednesday, August 6, 2025 |
TIME: | 8:00 a.m. Eastern Time 6:00 a.m. Mountain Time |
WEBCAST: |
|
Miguel Martin, Executive Chairman and Chief Executive Officer, and Simona King, Chief Financial Officer, will host the conference call and question and answer period. This weblink has also been posted to the Company's "Investor Info" link at under "Events".
About Aurora Cannabis
Aurora is opening the world to cannabis, serving both the medical and consumer markets across
Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB".
Forward Looking Information
This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law ("forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. Forward-looking statements made in this news release include, but are not limited to, statements regarding the timing for the release of the Company's fiscal 2026 Q1 financial statements and the conference call to discuss the results.
These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from
View original content to download multimedia:
SOURCE Aurora Cannabis Inc.